Elevated lactate levels, aberrant mTOR signaling, and the hypoxic conditions of the tumor microenvironment can all activate HIF-1α, which has been shown to impair NK cell effector function in a variety of settings. The gene discussed is HIF1A; the disease is neoplasm.